​

Achieve Life Sciences (ACHV) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

ACHV Stock Forecast

Achieve Life Sciences (ACHV) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $15.25, with a high of $18.00 and a low of $12.00. This represents a 112.10% increase from the last price of $7.19.

- $4 $8 $12 $16 $20 High: $18 Avg: $15.25 Low: $12 Last Closed Price: $7.19

ACHV Stock Rating

Achieve Life Sciences stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

ACHV Price Target Upside V Benchmarks

TypeNameUpside
StockAchieve Life Sciences112.10%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-46
Avg Price Target-$15.25$15.67
Last Closing Price$7.19$7.19$7.19
Upside/Downside-112.10%117.94%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 2639---12
Sep, 2638---11
Aug, 2627---9
Jul, 2627---9
Jun, 2626---8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 29, 2026Stifel Nicolaus$18.00$7.69134.07%150.35%
Aug 13, 2026Maxwell SkorMorgan Stanley$13.00$6.6994.32%80.81%
Aug 12, 2026Ryan DeschnerRaymond James$18.00$6.66170.27%150.35%
Aug 12, 2026Brandon FolkesH.C. Wainwright$12.00$6.7777.25%66.90%
Jun 26, 2026Raymond James$20.00$5.91238.41%178.16%
Apr 20, 2026Canaccord Genuity$13.00$4.25205.88%80.81%
May 13, 2024Francois BriseboisOppenheimer$5.50$2.42127.27%-23.50%
Nov 16, 2022Maxim Group$4.00$1.13253.98%-44.37%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2026H.C. WainwrightBuyBuyhold
Aug 13, 2026Morgan StanleyOverweightinitialise
Aug 12, 2026Raymond JamesStrong BuyStrong Buyhold
Aug 12, 2026UBSBuyBuyhold
Jun 23, 2026UBSBuyBuyhold
Nov 25, 2025CitigroupOutperforminitialise
Nov 24, 2025Raymond JamesStrong BuyStrong Buyhold
Sep 26, 2024Raymond JamesStrong Buyinitialise
May 13, 2024OppenheimerOutperformOutperformhold
Dec 12, 2023OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 $1 $2 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.05$-3.95$-1.50$-1.24$-1.25---
Avg Forecast$-3.92$-4.07$-1.56$-1.22$-1.14$-0.61$0.19$1.90
High Forecast$-3.92$-4.07$-1.52$-1.09$-0.92$0.07$0.21$1.90
Low Forecast$-3.92$-4.07$-1.59$-1.34$-1.38$-0.92$0.11$1.90
Surprise %3.32%-2.95%-3.85%1.64%9.65%---

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--------
Avg Forecast$40.00K$100.00K--$16.42M$31.10M$92.64M$198.95M
High Forecast$40.00K$100.00K--$16.42M$31.35M$95.77M$198.95M
Low Forecast$40.00K$100.00K--$16.42M$30.85M$89.52M$198.95M
Surprise %--------

Net Income Forecast

$-100M $-70M $-40M $-10M $20M $50M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-33.15M$-42.35M$-29.82M$-39.83M$-54.65M---
Avg Forecast$-77.72M$-80.60M$-30.87M$-24.01M$-22.78M$-8.43M$3.17M$37.67M
High Forecast$-77.72M$-80.60M$-30.17M$-21.52M$-18.18M$1.40M$4.23M$37.67M
Low Forecast$-77.72M$-80.60M$-31.56M$-26.49M$-27.37M$-18.26M$2.11M$37.67M
Surprise %-57.35%-47.46%-3.40%65.90%139.94%---

ACHV Forecast FAQ

Is Achieve Life Sciences stock a buy?

Achieve Life Sciences stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Achieve Life Sciences is a favorable investment for most analysts.

What is Achieve Life Sciences's price target?

Achieve Life Sciences's price target, set by 6 Wall Street analysts, averages $15.25 over the next 12 months. The price target range spans from $12 at the low end to $18 at the high end, suggesting a potential 112.10% change from the previous closing price of $7.19.

How does Achieve Life Sciences stock forecast compare to its benchmarks?

Achieve Life Sciences's stock forecast shows a 112.10% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Achieve Life Sciences over the past three months?

  • October 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 27.27% Strong Buy, 72.73% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 22.22% Strong Buy, 77.78% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Achieve Life Sciences’s EPS forecast?

Achieve Life Sciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.61, marking a -51.20% decrease from the reported $-1.25 in 2025. Estimates for the following years are $0.19 in 2027, and $1.9 in 2028.

What is Achieve Life Sciences’s revenue forecast?

Achieve Life Sciences's average annual revenue forecast for its fiscal year ending in December 2026 is $31.1M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $92.64M, and $198.95M for 2028.

What is Achieve Life Sciences’s net income forecast?

Achieve Life Sciences's net income forecast for the fiscal year ending in December 2026 stands at $-8.427M, representing a -84.58% decrease from the reported $-54.648M in 2025. Projections indicate $3.17M in 2027, and $37.67M in 2028.